Skip to content

The Role of Triphala Rasayana Regimen in Dyslipidaemia (-Medhodushti)

A Clinical Study to evaluate the efficacy of Triphala Rasayana regimen in dyslipidaemia (-Medhodushti).

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049545
Enrollment
23
Registered
2023-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Ch.Brahm prakash Ayurved charak Sansthan.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with total cholesterol above 200mg/dl or patients with triglycerides above 150 mg/dl or HDL below 50 mg/dl or LDL 130mg/dl. Patients who are ready to give consent with firm home address and contact no which is readily accessible during course of trial. Patient able to take oral powder medicine. Patients with BMI above 23 Patients with waist-hip ratio >0.80.

Exclusion criteria

Exclusion criteria: Pregnancy or lactating women. Patient who has any clinically significant or unstable medical or psychiatric illness. Patient having known case of systemic illness like Tuberculosis, Carcinoma, uncontrolled diabetes (HbA1C= 7) or RBS > 250 mg/dl, uncontrolled hypertension (B P = 140/90 mmHg). Substance abusers such alcohol. Patient who are taking part in other clinical trials that will influence the result of this study.

Design outcomes

Primary

MeasureTime frame
Improvement in lipid profileTimepoint: On 0th Day, Day 1st, Day 2nd,Day 17th,Day 32nd ,Day 47th, Day 77th.

Secondary

MeasureTime frame
Improvement in grading symptom of Medhodushti and Dhatusamyata and Vikaropshaman. Timepoint: On 0th Day, Day 1st, Day 2nd,Day 17th,Day 32nd ,Day 47th, Day 77th.

Countries

India

Contacts

Public ContactDr Swati Sandwal

Chaudhary Brahm Prakash Ayurved Charak Sansthan

dryogeshpandey@gmail.com9013858523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026